ArticleSultan Qaboos University medical journal2025
Assessing Vascular Biomarkers and Their Association with Hypertension in Paediatric Chronic Kidney Disease.
Article in Sultan Qaboos University medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to examine the correlation between children with chronic kidney disease (CKD) and endothelial dysfunction biomarkers, including asymmetric dimethylarginine (ADMA), angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A), as well as blood pressure and cardiovascular risk. Methods: This case-control study included children who were divided into 2 groups: children with CKD at different stages and healthy controls. The study was performed from November 2021 to October 2022 at El-Minia University hospitals and the general outpatient paediatric clinic at Minia University, Minya, Egypt. Blood pressure measurements were taken, and levels of ADMA, Ang-2 and VEGF-A were determined. Results: A total of 90 children divided into 2 groups (45 each) were included in this study. The results showed that children with CKD exhibited significantly higher ADMA, Ang-2 and VEGF-A levels compared to the control group. Both systolic and diastolic blood pressure showed a positive correlation with the elevated biomarkers, while the estimated glomerular filtration rate (e-GFR) demonstrated a negative association. Conclusions: Elevated levels of VEGF-A, Ang-2 and ADMA have been linked to increased cardiovascular risk and antihypertensive treatment in children with CKD. These biomarkers may prove valuable in clinical evaluations to improve therapy and outcomes for children with CKD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.